|
|
||||||||
a Division of Cardiovascular Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
b Department of General Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
c Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
Accepted for publication September 11, 2008.
* Address correspondence to Dr Emaminia, Division of Cardiovascular Surgery, Department of Surgery, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran (Email: emaminia{at}gmail.com).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The patient was a 53-year-old man who was admitted to the hospital for work-up of his face and upper extremity edema. Chest roentgenogram showed mediastinal widening on the right margin. Computed tomographic scan revealed a mass in the anterior mediastinum, filling the left brachiocephalic vein and extending to the right atrium through the SVC (Fig 1). Due to its extensive nature and the potential risks associated with the location of the mass, a decision was made to take the patient to the operating room emergently without any preoperative chemotherapy or radiation therapy.
|
Pathologic examination revealed a type AB thymoma (World Health Organization classification), which had directly invaded the left brachiocephalic vein. The patient was discharged home on postoperative day 4, and further management through chemotherapy and radiation therapy was pursued.
In the most recent computed tomographic scan 5 years after the operation, the diffuse and distant metastasis of the original tumor was remarkable. The Dacron graft (DuPont) was patent and the patient was free from any signs and symptoms indicative of SVC syndrome.
| Comment |
|---|
|
|
|---|
We believe that there have been 15 other cases of intracardiac thymomas reported in the literature aside from this report. The longest reported follow-up was 36 months, in which the patient returned with recurrence of SVC syndrome. The patient in this report was followed-up for 5 years, and the latest computed tomographic scan showed the graft to be patent.
The goal of surgery in such cases is to restore the blood flow from the brachiocephalic veins to the right atrium. This can be performed either by cleaning the SVC from the tumor bulk or through extra-anatomical grafts. Both biologic and synthetic materials, such as autologous vein, autologous, or bovine pericardium, and expanded polytetrafluoroethylene have been used in the venous system [4–6]. Doty and colleagues [4] believe in superiority of autologous vein, but more time is required to reconstruct a spiral vein graft and a long suture line, which may increase the thrombogenicity of the graft. On the other hand, expanded polytetrafluoroethylene grafts used in these patients, have reportedly proven to have excellent short-term and long-term results [5, 6]. However, the problem of flexion and kinking are prominent with long conduits [7].
Dong Lu and colleagues [7] described a case of SVC reconstruction using valved bovine jugular vein with excellent 42-month patency, although other reports discourage the use of such conduits due to thrombosis [8].
In conclusion, we report a rare case with invasive thymoma to the SVC and right atrium that underwent en bloc excision of the tumor with SVC being bypassed using a Dacron graft with excellent 5-year patency. Use of extra-anatomical conduits in the venous system is most probably safe and at times may even be lifesaving.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Venuta and E. A. Rendina Superior vena cava resection and reconstruction Eur J Cardiothorac Surg, January 18, 2012; (2012) ezr266v1. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |